Revenue: $4.1 million, a 54% year-over-year increase and 30% sequential growth. Gross Profit: $2.7 million, a 94% increase year-over-year. Gross Margin: 65% for continuing operations, up from 51% in ...

The latest announcement is out from MindWalk Holdings ( (HYFT)). On December 15, 2025, MindWalk Holdings reported record financial growth for the second quarter of fiscal 2026, with a 54% increase in ...

MindWalk Holdings Corp. (HYFT) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.07 per share a year ago. These ...

MindWalk highlighted progress in its AI-driven asset pipeline, including advancements in its GLP1 receptor agonist program, which achieved receptor activation above semaglutide in in vitro assays. The ...

MindWalk (NASDAQ: HYFT), a BioNative AI biotherapeutic research and technology company combining in silico and wet lab operations for biologics discovery and development, today announced financial ...

Good morning, ladies and gentlemen, and thank you for joining us today for MindWalk's Second Quarter Fiscal 2026 Earnings Call. We appreciate your time and interest in MindWalk, formerly ImmunoPrecise ...

VICTORIA, British Columbia--(BUSINESS WIRE)-- MindWalk (NASDAQ: HYFT), a BioNative AI biotherapeutic research and technology company combining in silico and wet lab operations for biologics discovery ...

Shares of MindWalk Holdings Corp. (NASDAQ: HYFT) rose sharply in pre-market trading ahead of quarterly earnings. Wall Street expects MindWalk to report a quarterly loss of 1 cent per share on revenue ...